GALENICA S.A.

Founded in 1974, Galenica is a leading Greek pharmaceutical company dedicated to providing innovative therapeutic solutions across prescription and over-the-counter drugs, supplements, and medical devices. For over four decades, we have advanced human health through scientific innovation and a commitment to quality. Our production facilities in Chalkida and Kryoneri are EU GMP-certified and FDA-approved, producing various pharmaceutical forms including injectables, pills, and liquids. We adhere to strict safety, quality, and environmental standards, ensuring our products are trusted by healthcare providers and patients. Our core business includes contract manufacturing, in-licensing, and exports, and we proudly collaborate with trusted partners worldwide to uphold transparency, ethics, and sustainability. With a distribution network spanning over 35 countries across Europe, Africa, Asia, North America, South America, and the Middle East, we are constantly expanding our reach. Sustainability is a key pillar of our philosophy, and we continuously work to reduce our environmental footprint through renewable energy usage, waste reduction, and lower greenhouse gas emissions. At Galenica, our human-centric approach leads us to enhance lives across various therapeutic categories. We strive to deliver healthcare solutions that improve quality of life, offering fast, effective relief. Guided by a global vision and an unwavering commitment to excellence, we are shaping the future of healthcare.